Join
Live feed
·
INSIDERFilingvia Quantisnow
CytoMed Therapeutics Limited logo

Amendment: Director Choo Chee Kong bought $300,000 worth of ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED (200,000 units at $1.50), increasing direct ownership by 46% to 630,324 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GDTC (CytoMed Therapeutics Limited) and more on Quantisnow.

Amendment: Director Choo Chee Kong bought $300,000 worth of ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED (200,000 units at $1.50), increasing direct ownership by 46% to 630,324 units (SEC Form 4) | Quantisnow